Aignostics Opens Early Access to PathoSearch
Aignostics announced in a press release the early access release of PathoSearch, a visual search engine for pathology cases. Users can submit a screenshot of a region on an H&E slide to retrieve diagnosed reference cases with similar morphology.
PathoSearch uses a multi center reference database and embeddings from Atlas 2, a pathology foundation model created with Mayo Clinic. Its results link to cases annotated and validated by pathologists, with many also confirmed through molecular testing.
The database contains more than 310,000 whole slide images from over 35,000 cases. It covers more than 300 diagnostic entities across at least 27 organs, with an initial focus on malignant tumors. Aignostics plans to expand it beyond one million images before general availability.
The first integration is available through Techcyte Fusion AP. PathoSearch is free during early access and is limited to research use. It is not intended for diagnostic procedures.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 28 Zocdoc Opens Healthcare Booking Infrastructure to AI Agents Oct 27 Anthropic Reports Early Claude Results in Drug Development Oct 27 Insilico Reports Early ISM6331 Responses in Mesothelioma Oct 27 UnitedHealthcare Expands Avery AI Assistant to 21 Million Members Oct 27 Atlas Bio raises $12.5 million for virtual drug trialsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Sophont launches Holon-S1 to predict gene activity from pathology slides
Illumina Adds Three Research Tools to BioInsight Platform
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
HistoIndex and A*STAR Partner on Fibrosis Drug Evaluation
Pathos AI Raises $237 Million at $3 Billion Valuation
Daily AI Brief: the AI news that matters, in your inbox.